MNEXSPIVAX Trademark

Trademark Overview


On Thursday, January 4, 2024, a trademark application was filed for MNEXSPIVAX with the United States Patent and Trademark Office. The USPTO has given the MNEXSPIVAX trademark a serial number of 98341751. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 29, 2025. This trademark is owned by ModernaTX, Inc.. The MNEXSPIVAX trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
mnexspivax

General Information


Serial Number98341751
Word MarkMNEXSPIVAX
Filing DateThursday, January 4, 2024
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 29, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 2, 2024

Trademark Statements


Goods and ServicesVaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 4, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameModernaTX, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameModernaTX, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Sunday, March 31, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 4, 2024NEW APPLICATION ENTERED
Sunday, March 31, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, March 31, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, March 31, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, March 31, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, April 21, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 25, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, May 25, 2024ASSIGNED TO EXAMINER
Wednesday, June 12, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 27, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, February 14, 2025SOU TEAS EXTENSION RECEIVED
Friday, February 14, 2025SOU EXTENSION 1 FILED
Friday, February 14, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 14, 2025SOU EXTENSION 1 GRANTED
Monday, September 29, 2025ABANDONMENT - NO USE STATEMENT FILED
Monday, September 29, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords


mnexspivax human vaccines